Fonar competitors

Public company CEO and Board Director with 20+ years of healthcare technology experience:• Environments: Start-up, private-equity, Fortune 20• Healthcare Sectors: Radiology, sports-medicine, surgery, pre-clinical imaging, gastro-hepatology • Offerings: Class-II, Class-III, capital equipment, services, and implantable devices• Key skills: Raising capital (IPO). Building new businesses. Driving innovation. Leading turnarounds

Geoff Martha is firmly establishing Medtronic as the undisputed global leader in healthcare technology. As chairman & CEO, Geoff leads the $30 billion company and its 90,000 employees in pursuit of fulfilling the Medtronic Mission to use technology to improve human welfare. He is recognized as a driven and innovative executive - ranking in Modern Healthcare’s 100 Most Influential People in Healthcare in 2020 and listed as the #1 CEO in healthcare technology by the Healthcare Technology Report in 2021.Geoff became CEO in April 2020. Under his leadership, Medtronic is putting the ‘tech’ in MedTech, leveraging the latest advances in cutting edge technology to transform healthcare. Fortune Magazine named Medtronic among the top 15 companies for its 2020 “Change the World” list, recognizing its swift efforts during the pandemic, and listed the company on its 2021 list of Most Admired Companies.Geoff joined Medtronic in 2011, and notably led the acquisition and integration of Covidien, the largest acquisition in the medical technology industry. Before joining Medtronic, Geoff spent 19 years at GE Healthcare and GE Capital.Geoff is a member of the Business Roundtable, and the World Economic Forum’s International Business Council. He also co-chairs the Taskforce on Health and Life Sciences for B20, a G20 engagement group.An ardent supporter of philanthropic and diversity initiatives, Geoff serves on the board of directors for the Medtronic Foundation, Children’s HeartLink, and the Northside Achievement Zone. He is part of OneTen, a coalition of cross-industry leaders committed to breaking down systemic barriers for Black Americans. He also serves as Medtronic’s Executive Sponsor to FIRST Robotics.Geoff received a bachelor’s degree in Finance from Pennsylvania State University, where he currently serves on the Development Council for its College of Liberal Arts. He was also captain of the Penn State men’s hockey team and later inducted into its Hockey Hall of Fame.

Prior to founding ABT in 2006, Dr. Nutt co-founded CTI Molecular Imaging, Inc. in 1983. He was Vice President of Research and Development from 1983 through 1998 when he became the President of CTI PET Systems, a joint venture between Siemens and CTI. In 2002 he became the President and Chief Executive Officer of CTI Molecular Imaging, Inc. a NASDAQ public company. Dr. Nutt led the negotiations resulting in the sale of CTI to Siemens in 2005. As Vice President of R&D, Dr. Nutt had more than 30 patents in the field of molecular imaging, authored and co-authored a large number of technical publications and has presented invited talks at numerous conferences. Prior to founding CTI Molecular Imaging, Dr. Nutt was the co-founder of several other companies including Technology for Energy Corporation, Radio Systems Corporation and Delta M Corporation. Dr. Nutt was the Vice President of EG&G ORTEC during the time frame of 1969 through 1979 where he was responsible for developing many innovations in the field of nuclear physics instrumentation. Prior to ORTEC he was a researcher at the Oak Ridge National Laboratory and taught Electrical Engineering at the University of Tennessee. Dr. Nutt holds a BS, MS and PhD from the University of Tennessee and was awarded in 1997 the Dean Daugherty award for his outstanding achievements, the highest Engineering Alumni honors. Dr. Nutt is a Fellow of the IEEE and was named by the organization the Outstanding Engineering for the Eastern part of the US in 1999 for his contributions to molecular imaging. He was also awarded the Distinguished Scientist of the Year by the Academy of Molecular Imaging in year 1999.

Sami Levi works at ISENSIX and a CEO at Aquatec Water System Inc and CEO/CFO at ISENSIX and is based in Irvine, California. He has worked as President at Sigma Medical Imaging Inc and Dir:Mergers & Acquisitions at Fairchild. Sami attended The Wharton School between 1986 and 1988, University of Pennsylvania between 1983 and 1986, and Robert College.